Nifty
:
16352.45
Sensex
:
54884.66
182.30 (1.13%)
632.13 (1.17%)
Nifty
Sensex
:
:
16352.45
54884.66
182.30 (1.13%)
632.13 (1.17%)

National Peroxide Ltd.

Chemicals

Rating :
43/99

BSE: 500298 | NSE: NATPEROXID

NSE BSE
1447.50
27-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  1457.10
  •  1463.65
  •  1431.05
  •  1430.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  199
  •  20.88
  •  2620.00
  •  1414.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 822.28
  • 154.31
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 939.48
  • 0.35%
  • 0.92

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.76%
  • 1.39%
  • 25.21%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.64%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.35
  • -1.60
  • -18.85

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.51
  • -8.51
  • -27.59

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.70
  • -11.33
  • -48.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.01
  • 25.55
  • 32.77

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.96
  • 2.05
  • 1.04

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.61
  • 20.34
  • 23.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
49.96
64.15
-22.12%
79.74
66.51
19.89%
67.55
53.88
25.37%
28.69
30.46
-5.81%
Expenses
52.08
58.45
-10.90%
62.34
49.92
24.88%
54.68
35.78
52.82%
39.84
28.27
40.93%
EBITDA
-2.12
5.70
-
17.41
16.59
4.94%
12.88
18.10
-28.84%
-11.16
2.19
-
EBIDTM
-4.24%
8.89%
21.83%
24.94%
19.06%
33.59%
-38.91%
7.21%
Other Income
1.80
3.55
-49.30%
1.27
3.25
-60.92%
3.97
3.20
24.06%
3.18
2.79
13.98%
Interest
1.96
2.91
-32.65%
2.08
3.23
-35.60%
2.31
3.12
-25.96%
2.48
3.39
-26.84%
Depreciation
4.36
4.24
2.83%
4.44
4.38
1.37%
4.37
4.46
-2.02%
4.26
4.41
-3.40%
PBT
0.36
-10.82
-
12.15
12.22
-0.57%
10.17
13.71
-25.82%
-14.73
-2.82
-
Tax
0.41
-2.45
-
3.32
3.22
3.11%
2.88
-8.62
-
-4.08
-1.03
-
PAT
-0.05
-8.37
-
8.84
9.00
-1.78%
7.29
22.34
-67.37%
-10.65
-1.79
-
PATM
-0.10%
-13.05%
11.08%
13.54%
10.79%
41.45%
-37.11%
-5.87%
EPS
-0.09
-14.57
-
15.38
15.67
-1.85%
12.68
38.86
-67.37%
-18.52
-3.11
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
225.94
215.01
191.23
402.28
306.31
233.09
233.99
196.75
235.86
212.89
154.65
Net Sales Growth
5.09%
12.44%
-52.46%
31.33%
31.41%
-0.38%
18.93%
-16.58%
10.79%
37.66%
 
Cost Of Goods Sold
109.36
77.49
82.23
86.69
82.20
60.54
80.09
74.00
66.92
52.99
38.44
Gross Profit
116.58
137.51
109.01
315.60
224.10
172.55
153.91
122.75
168.95
159.90
116.21
GP Margin
51.60%
63.96%
57.00%
78.45%
73.16%
74.03%
65.78%
62.39%
71.63%
75.11%
75.14%
Total Expenditure
208.94
169.85
165.66
175.41
160.83
162.63
197.66
174.49
173.58
145.61
107.10
Power & Fuel Cost
-
33.95
26.05
32.78
27.12
30.20
32.92
30.54
33.98
31.09
19.75
% Of Sales
-
15.79%
13.62%
8.15%
8.85%
12.96%
14.07%
15.52%
14.41%
14.60%
12.77%
Employee Cost
-
25.58
26.33
23.61
22.55
23.48
19.37
17.06
16.83
13.95
10.69
% Of Sales
-
11.90%
13.77%
5.87%
7.36%
10.07%
8.28%
8.67%
7.14%
6.55%
6.91%
Manufacturing Exp.
-
8.41
11.19
7.96
9.13
33.41
29.88
27.71
25.63
28.51
23.13
% Of Sales
-
3.91%
5.85%
1.98%
2.98%
14.33%
12.77%
14.08%
10.87%
13.39%
14.96%
General & Admin Exp.
-
10.43
6.73
6.94
6.50
5.45
10.41
6.78
9.11
7.14
5.45
% Of Sales
-
4.85%
3.52%
1.73%
2.12%
2.34%
4.45%
3.45%
3.86%
3.35%
3.52%
Selling & Distn. Exp.
-
4.09
3.59
5.55
3.67
0.09
22.95
17.30
19.57
11.93
10.48
% Of Sales
-
1.90%
1.88%
1.38%
1.20%
0.04%
9.81%
8.79%
8.30%
5.60%
6.78%
Miscellaneous Exp.
-
9.88
9.54
11.89
9.66
9.45
2.05
1.09
1.54
0.00
10.48
% Of Sales
-
4.60%
4.99%
2.96%
3.15%
4.05%
0.88%
0.55%
0.65%
0%
0.16%
EBITDA
17.01
45.16
25.57
226.87
145.48
70.46
36.33
22.26
62.28
67.28
47.55
EBITDA Margin
7.53%
21.00%
13.37%
56.40%
47.49%
30.23%
15.53%
11.31%
26.41%
31.60%
30.75%
Other Income
10.22
12.78
17.95
19.11
10.14
6.19
8.12
6.49
6.19
4.77
2.15
Interest
8.83
12.66
2.74
0.73
0.51
2.21
5.38
4.68
0.22
0.35
0.41
Depreciation
17.43
17.50
11.23
9.23
9.19
8.93
8.96
7.21
9.73
11.00
10.02
PBT
7.95
27.78
29.56
236.02
145.92
65.51
30.11
16.86
58.52
60.70
39.27
Tax
2.53
-8.88
11.64
82.22
51.14
19.19
10.74
10.18
19.78
20.64
11.41
Tax Rate
31.82%
-72.25%
39.38%
34.84%
34.79%
33.19%
36.79%
60.38%
33.12%
34.00%
29.06%
PAT
5.43
21.18
17.92
153.80
95.84
38.64
18.45
6.68
39.94
40.06
27.86
PAT before Minority Interest
5.43
21.18
17.92
153.80
95.84
38.64
18.45
6.68
39.94
40.06
27.86
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
2.40%
9.85%
9.37%
38.23%
31.29%
16.58%
7.88%
3.40%
16.93%
18.82%
18.01%
PAT Growth
-74.36%
18.19%
-88.35%
60.48%
148.03%
109.43%
176.20%
-83.27%
-0.30%
43.79%
 
EPS
9.53
37.16
31.44
269.82
168.14
67.79
32.37
11.72
70.07
70.28
48.88

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
1,066.77
802.10
1,173.79
1,016.86
741.59
224.00
212.46
209.66
179.81
149.77
Share Capital
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
5.75
Total Reserves
1,061.02
796.36
1,168.04
1,011.11
735.84
218.25
206.72
203.92
174.06
144.02
Non-Current Liabilities
216.48
215.55
110.11
36.51
27.44
126.98
137.87
18.82
17.62
71.69
Secured Loans
0.00
0.00
69.69
0.00
0.00
10.00
30.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
183.31
176.18
3.10
2.55
2.79
87.51
80.37
1.27
0.55
55.94
Current Liabilities
159.70
217.08
58.54
39.40
38.36
48.87
76.15
62.46
40.65
36.43
Trade Payables
20.04
18.68
23.99
20.27
19.23
18.06
25.20
22.53
25.49
20.08
Other Current Liabilities
129.18
187.00
16.21
13.38
14.39
22.21
23.59
5.74
2.90
2.03
Short Term Borrowings
9.33
4.68
10.00
0.00
1.05
0.33
22.99
4.04
1.03
5.26
Short Term Provisions
1.15
6.72
8.34
5.75
3.68
8.26
4.36
30.15
11.23
9.04
Total Liabilities
1,442.95
1,234.73
1,342.44
1,092.77
807.39
399.85
426.48
290.94
238.08
257.89
Net Block
342.13
372.39
165.75
169.65
178.48
179.67
187.37
116.63
110.42
117.82
Gross Block
395.96
410.87
193.00
187.73
187.41
322.83
321.57
243.31
230.49
226.90
Accumulated Depreciation
53.83
38.48
27.25
18.07
8.92
143.16
134.21
126.68
120.07
109.08
Non Current Assets
1,278.34
1,045.34
1,009.60
883.09
678.48
278.99
283.17
176.01
124.97
181.55
Capital Work in Progress
2.53
0.00
75.40
5.64
1.68
3.09
3.98
40.92
3.15
2.58
Non Current Investment
746.02
492.40
742.63
691.25
487.41
4.33
4.33
4.33
3.00
2.17
Long Term Loans & Adv.
187.36
180.19
25.81
16.49
10.76
91.75
87.50
14.13
8.40
58.97
Other Non Current Assets
0.30
0.36
0.01
0.06
0.14
0.15
0.00
0.00
0.00
0.00
Current Assets
164.61
189.39
332.84
209.68
128.92
120.84
143.31
114.94
113.10
76.34
Current Investments
0.21
0.00
7.84
70.37
50.26
5.78
8.31
9.02
57.34
22.71
Inventories
16.95
24.40
31.81
14.73
11.11
14.11
16.00
23.99
8.19
10.96
Sundry Debtors
23.84
32.25
30.59
53.25
33.17
32.66
37.16
32.51
31.67
24.36
Cash & Bank
7.49
2.96
15.00
3.70
0.47
1.66
1.24
1.38
1.24
1.67
Other Current Assets
116.11
13.16
3.30
1.07
33.91
66.63
80.59
48.04
14.67
16.64
Short Term Loans & Adv.
113.75
116.62
244.30
66.56
32.31
65.94
80.25
47.74
14.43
16.32
Net Current Assets
4.91
-27.68
274.30
170.28
90.56
71.98
67.16
52.48
72.45
39.91
Total Assets
1,442.95
1,234.73
1,342.44
1,092.77
807.40
399.83
426.48
290.95
238.07
257.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
61.04
16.11
148.04
94.71
59.73
22.27
21.52
29.09
41.91
47.24
PBT
12.29
29.56
236.02
146.97
57.82
29.19
16.86
59.72
60.70
39.27
Adjustment
31.65
-2.94
-8.49
-0.08
16.53
8.65
7.26
4.01
6.92
9.72
Changes in Working Capital
23.27
-0.07
-0.24
-12.08
-0.88
-8.42
1.98
-16.34
-5.14
6.59
Cash after chg. in Working capital
67.22
26.55
227.28
134.82
73.48
29.43
26.10
47.39
62.48
55.57
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.18
-10.44
-79.24
-40.10
-13.74
-7.15
-4.58
-18.31
-20.57
-8.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-7.27
-38.80
-175.12
-56.37
-32.69
29.53
-74.98
-21.84
-29.95
-34.94
Net Fixed Assets
12.38
-142.47
-75.03
-4.28
136.83
-0.37
-41.32
-50.59
-4.16
-33.83
Net Investments
-91.18
15.03
61.83
-83.23
-163.14
2.53
0.71
48.32
-34.63
-2.21
Others
71.53
88.64
-161.92
31.14
-6.38
27.37
-34.37
-19.57
8.84
1.10
Cash from Financing Activity
-49.18
14.13
34.66
-35.21
-28.24
-51.38
54.24
-7.24
-12.56
-12.00
Net Cash Inflow / Outflow
4.58
-8.57
7.58
3.13
-1.19
0.42
0.79
0.00
-0.60
0.30
Opening Cash & Equivalents
2.22
10.79
3.21
0.08
1.27
0.85
0.06
0.06
0.66
0.36
Closing Cash & Equivalent
6.80
2.22
10.79
3.21
0.08
1.27
0.85
0.06
0.06
0.66

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
1856.21
1395.69
2042.43
1769.37
1290.39
389.76
369.69
364.82
312.87
260.60
ROA
1.58%
1.39%
12.63%
10.09%
6.40%
4.47%
1.86%
15.10%
16.16%
12.50%
ROE
2.27%
1.81%
14.04%
10.90%
8.00%
8.45%
3.16%
20.51%
24.31%
19.92%
ROCE
2.32%
2.91%
20.86%
16.67%
11.92%
12.81%
8.63%
30.38%
36.35%
27.01%
Fixed Asset Turnover
0.53
0.63
2.11
1.68
1.03
0.81
0.78
1.11
1.04
0.85
Receivable days
47.61
59.97
38.04
50.09
45.79
48.83
57.97
44.64
42.96
55.28
Inventory Days
35.10
53.64
21.11
14.97
17.54
21.06
33.27
22.38
14.68
32.79
Payable days
91.17
53.33
43.29
45.18
44.39
40.45
51.97
47.57
55.81
72.30
Cash Conversion Cycle
-8.46
60.29
15.86
19.88
18.94
29.44
39.27
19.46
1.83
15.77
Total Debt/Equity
0.12
0.20
0.07
0.00
0.01
0.14
0.34
0.02
0.01
0.04
Interest Cover
1.97
11.80
323.92
291.52
27.16
6.42
4.60
276.84
175.83
97.36

Top Investors:

iepf

Annual Reports:

FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012

News Update:


  • National Peroxide - Quarterly Results
    12th May 2022, 19:16 PM

    Read More
  • National Peroxide resumes operations at Kalyan plant
    21st Mar 2022, 12:28 PM

    Further, during this period the company has also carried out routine preventive maintenance activities to improve plant performance and efficiency

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.